Overview

Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)

Status:
Completed
Trial end date:
2020-08-30
Target enrollment:
Participant gender:
Summary
the current study is to evaluate the efficacy and safety of Montelukast in the treatment of patients with non-alcoholic steatohepatitis (NASH).
Phase:
Phase 4
Details
Lead Sponsor:
Tanta University
Treatments:
Montelukast